These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 15194827)

  • 1. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
    Black S; Shinefield H; Baxter R; Austrian R; Bracken L; Hansen J; Lewis E; Fireman B
    Pediatr Infect Dis J; 2004 Jun; 23(6):485-9. PubMed ID: 15194827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
    Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults.
    Black S; Shinefield H; Baxter R; Austrian R; Elvin L; Hansen J; Lewis E; Fireman B
    Vaccine; 2006 Apr; 24 Suppl 2():S2-79-80. PubMed ID: 16823937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.
    Black SB; Shinefield HR; Hansen J; Elvin L; Laufer D; Malinoski F
    Pediatr Infect Dis J; 2001 Dec; 20(12):1105-7. PubMed ID: 11740313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.
    Hsu K; Pelton S; Karumuri S; Heisey-Grove D; Klein J;
    Pediatr Infect Dis J; 2005 Jan; 24(1):17-23. PubMed ID: 15665705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
    Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.
    Singleton RJ; Hennessy TW; Bulkow LR; Hammitt LL; Zulz T; Hurlburt DA; Butler JC; Rudolph K; Parkinson A
    JAMA; 2007 Apr; 297(16):1784-92. PubMed ID: 17456820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
    Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
    Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.
    Haddy RI; Perry K; Chacko CE; Helton WB; Bowling MG; Looney SW; Buck GE
    Pediatr Infect Dis J; 2005 Apr; 24(4):320-3. PubMed ID: 15818291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
    Kyaw MH; Lynfield R; Schaffner W; Craig AS; Hadler J; Reingold A; Thomas AR; Harrison LH; Bennett NM; Farley MM; Facklam RR; Jorgensen JH; Besser J; Zell ER; Schuchat A; Whitney CG;
    N Engl J Med; 2006 Apr; 354(14):1455-63. PubMed ID: 16598044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.
    Block SL; Hedrick J; Harrison CJ; Tyler R; Smith A; Findlay R; Keegan E
    Pediatr Infect Dis J; 2004 Sep; 23(9):829-33. PubMed ID: 15361721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
    Lexau CA; Lynfield R; Danila R; Pilishvili T; Facklam R; Farley MM; Harrison LH; Schaffner W; Reingold A; Bennett NM; Hadler J; Cieslak PR; Whitney CG;
    JAMA; 2005 Oct; 294(16):2043-51. PubMed ID: 16249418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon.
    Frazão N; Brito-Avô A; Simas C; Saldanha J; Mato R; Nunes S; Sousa NG; Carriço JA; Almeida JS; Santos-Sanches I; de Lencastre H
    Pediatr Infect Dis J; 2005 Mar; 24(3):243-52. PubMed ID: 15750461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Kaplan SL; Mason EO; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ
    Pediatrics; 2004 Mar; 113(3 Pt 1):443-9. PubMed ID: 14993532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotype prevalence of occult pneumococcal bacteremia.
    Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
    Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
    Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
    Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children.
    Pelton SI; Klein JO
    Pediatrics; 2002 Oct; 110(4):805-14. PubMed ID: 12359799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conjugate vaccine for the prevention of pediatric pneumococcal disease.
    Murray D; Jackson C
    Mil Med; 2002 Aug; 167(8):671-7. PubMed ID: 12188240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia.
    Steenhoff AP; Shah SS; Ratner AJ; Patil SM; McGowan KL
    Clin Infect Dis; 2006 Apr; 42(7):907-14. PubMed ID: 16511752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.